IR-Med (IRME) has provided an update.
IR-Med, Inc. has recently undergone significant changes with the immediate termination of Tzur Di-Cori as CEO, along with the dismissal of most of its workforce due to financial challenges. The company now plans to scale back operations until they secure adequate funding to sustain their activities. This shake-up comes despite no reported disagreements on company operations, policies, or practices.
For detailed information about IRME stock, go to TipRanks’ Stock Analysis page.